Comparison Between Intravenous Ondanosteron and Metclopromide Versus Ondanesteron and Dexamethasone Effects on the Prevention of Postoperative Nausea and Vomiting in Cesarean Section

PHASE4CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

February 5, 2025

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2025

Conditions
Postoperative Nausea and Vomiting
Interventions
DRUG

Ondanesterone plus dexamethasone combination

"Group D: Ondanesterone 4mg plus dexamethasone 8mg All the drugs will be prepared and diluted by normal saline in 10 ml syringe by an anesthesiologist who is not included in the study.~The drugs will be slowly injected intravenous 15 minute from spinal anesthesia."

DRUG

ondanesterone plus metoclopramide combination

"Group M: ondanesterone 4mg plus metoclopramide 10 mg All the drugs will be prepared and diluted by normal saline in 10 ml syringe by an anesthesiologist who is not included in the study.~The drugs will be slowly injected intravenous 15 minute from spinal anesthesia."

Trial Locations (1)

41522

Suez Canal University Hospitals, Ismailia

All Listed Sponsors
lead

Aiman Al-Touny

OTHER

NCT06810531 - Comparison Between Intravenous Ondanosteron and Metclopromide Versus Ondanesteron and Dexamethasone Effects on the Prevention of Postoperative Nausea and Vomiting in Cesarean Section | Biotech Hunter | Biotech Hunter